GS I›ST-3.1.2›Vaccines — mRNA, recombinant; COVAXIN; Cervavac

Vaccines — mRNA, recombinant; COVAXIN; Cervavac

ST-3.1.2Core
0%

0/5 stages complete · 0% coverage

Exam Strategy

UPSC has tested vaccine technology post-2020 with focus on India's indigenous vaccines and platform technologies. Questions appear as standalone factual recall or linked to public health policy. Examiners test distinction between vaccine types, manufacturing processes, and India's self-reliance narrative. Common pitfall: confusing mRNA mechanism with viral vector platforms.

High-yield hooks
1

mRNA vaccines encode spike protein synthesis in host cells

2

COVAXIN is inactivated virus platform, not mRNA

3

Cervavac targets HPV for cervical cancer prevention

4

Recombinant vaccines use genetically engineered antigens

5

India's Atmanirbhar Bharat vaccine independence strategy

Coverage — 0/8 done
0%
SCANSCIENCE/BIOTECHNOLOGYPOLITY/PUBLIC-HEALTHECONOMY/ATMANIRBHAR-BHARAT